API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
14
PharmaCompass offers a list of Oxybutynin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxybutynin Hydrochloride manufacturer or Oxybutynin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxybutynin Hydrochloride manufacturer or Oxybutynin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Oxybutynin Hydrochloride API Price utilized in the formulation of products. Oxybutynin Hydrochloride API Price is not always fixed or binding as the Oxybutynin Hydrochloride Price is obtained through a variety of data sources. The Oxybutynin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxybutynin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxybutynin Hydrochloride, including repackagers and relabelers. The FDA regulates Oxybutynin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxybutynin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxybutynin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxybutynin Hydrochloride supplier is an individual or a company that provides Oxybutynin Hydrochloride active pharmaceutical ingredient (API) or Oxybutynin Hydrochloride finished formulations upon request. The Oxybutynin Hydrochloride suppliers may include Oxybutynin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Oxybutynin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxybutynin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxybutynin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Oxybutynin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Oxybutynin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxybutynin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Oxybutynin Hydrochloride USDMF includes data on Oxybutynin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxybutynin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxybutynin Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxybutynin Hydrochloride Drug Master File in Japan (Oxybutynin Hydrochloride JDMF) empowers Oxybutynin Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxybutynin Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Oxybutynin Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxybutynin Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Oxybutynin Hydrochloride Drug Master File in Korea (Oxybutynin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxybutynin Hydrochloride. The MFDS reviews the Oxybutynin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Oxybutynin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Oxybutynin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxybutynin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Oxybutynin Hydrochloride suppliers with KDMF on PharmaCompass.
A Oxybutynin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Oxybutynin Hydrochloride Certificate of Suitability (COS). The purpose of a Oxybutynin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxybutynin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxybutynin Hydrochloride to their clients by showing that a Oxybutynin Hydrochloride CEP has been issued for it. The manufacturer submits a Oxybutynin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxybutynin Hydrochloride CEP holder for the record. Additionally, the data presented in the Oxybutynin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxybutynin Hydrochloride DMF.
A Oxybutynin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxybutynin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxybutynin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Oxybutynin Hydrochloride written confirmation (Oxybutynin Hydrochloride WC) is an official document issued by a regulatory agency to a Oxybutynin Hydrochloride manufacturer, verifying that the manufacturing facility of a Oxybutynin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxybutynin Hydrochloride APIs or Oxybutynin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxybutynin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxybutynin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxybutynin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxybutynin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxybutynin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxybutynin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxybutynin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxybutynin Hydrochloride suppliers with NDC on PharmaCompass.
Oxybutynin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxybutynin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxybutynin Hydrochloride GMP manufacturer or Oxybutynin Hydrochloride GMP API supplier for your needs.
A Oxybutynin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Oxybutynin Hydrochloride's compliance with Oxybutynin Hydrochloride specifications and serves as a tool for batch-level quality control.
Oxybutynin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Oxybutynin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxybutynin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxybutynin Hydrochloride EP), Oxybutynin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxybutynin Hydrochloride USP).